Physician profile
Achu F Mofor
NPI 1053529685
$6,619.34
in general payments reported to CMS, 2019-2025
34 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $125 · 2021: $527 · 2022: $713 · 2023: $1,554 · 2024: $1,655 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,887.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,490.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,072.27 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $648.69 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $578.37 | 2022-2025 | |
| Pfizer INC. | $380.97 | 2022-2025 | |
| Dexcom, INC. | $320.18 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $281.83 | 2021-2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $259.55 | 2023-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $163.34 | 2022-2025 | |
| Glaxosmithkline, LLC. | $142.51 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $140.80 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.77 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $118.43 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $90.27 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $88.86 | 2023-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.76 | 2025 | Otezla, Repatha, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.96 | 2024-2025 | Xifaxan, Trulance |
| Corcept Therapeutics | $69.37 | 2024-2025 | Korlym |
| Beta Bionics, INC. | $55.18 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Boston Scientific Corporation | $55.14 | 2025 | Wavewriter Alpha Prime 16 |
| Inari Medical, INC. | $51.90 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $41.33 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $32.00 | 2022-2023 | Keveyis |
| Edwards Lifesciences Corporation | $31.99 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $31.15 | 2022-2023 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $28.37 | 2022 | |
| Daiichi Sankyo INC. | $27.46 | 2025 | Injectafer |
| Astellas Pharma US INC | $23.52 | 2023 | Veozah |
| Lundbeck LLC | $22.06 | 2023 | Vyepti |
| Cvrx, INC. | $21.13 | 2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $15.15 | 2023 | Eliquis |
| Alk-Abello, INC | $15.10 | 2024 | Ragwitek, Odactra, Grastek |
| Azurity Pharmaceuticals, INC. | $14.07 | 2023 | Horizant |
| Impel Pharmaceuticals INC. | $13.20 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Achu Mofor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.